Get access

Identification of Kazinol Q, a Natural Product from Formosan Plants, as an Inhibitor of DNA Methyltransferase

Authors

  • Jing-Ru Weng,

    Corresponding author
    1. Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
    • Correspondence to: Jing-Ru Weng, Ph.D, Department of Biological Science and Technology, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan.

      E-mail: columnster@gmail.com

    Search for more papers by this author
  • I-Lu Lai,

    1. Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA
    Search for more papers by this author
  • Hsiao-Ching Yang,

    1. Department of Chemistry, Fu Jen Catholic University, New Taipei, Taiwan
    Search for more papers by this author
  • Chun-Nan Lin,

    1. Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
    2. Faculty of Fragrance and Cosmetics, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
    Search for more papers by this author
  • Li-Yuan Bai

    1. Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
    2. School of Medicine, China Medical University, Taichung, Taiwan
    Search for more papers by this author

Abstract

DNA methylation plays a pivotal role in the epigenetic regulation of the transcription of a number of cancer-related genes, thereby representing an important target for cancer prevention and treatment. In our search for DNA methyltransferase (DNMT) inhibitors from Formosan plants, by screening against a library consisting of 12 structurally distinct natural products, we identified kazinol Q {4-[6-(1,1-dimethyl-allyl)-7-hydroxy-chroman-2-yl]-3,6-bis-(3-methyl-but-2-enyl)-benzene-1,2-diol} as an inhibitor of recombinant DNMT1 with IC50 of 7 μM. The effect of kazinol Q on DNMT inhibition was validated by its ability to reactivate the expression of a DNA methylation-silenced gene, E-cadherin, in MDA-MB-231 breast cancer cells. Moreover, kazinol Q suppressed the proliferation of MCF-7 breast and LNCaP prostate cancer cells, in part, through apoptosis induction. The role of DNMT1 inhibition in mediating kazinol Q's antiproliferative effect was supported by the protective effect of ectopic expression of DNMT1 on kazinol Q-induced cell death. Molecular modeling analysis suggests that kazinol Q inhibited DNMT activity by competing with cytosine binding, a mechanism similar to that described for (-)-epigallocatechin-3-gallate (EGCG). Relative to EGCG, kazinol Q exhibits several desirable features for drug development, including chemical stability and increased hydrophobicity, and might have therapeutic relevance to cancer treatment. Copyright © 2013 John Wiley & Sons, Ltd.

Get access to the full text of this article

Ancillary